MULTICENTER in Slovenian translation

• multicentrični
• večcentričnih
• multicentrična
• multicentrično
• multicentričnih

Examples of using Multicenter in English and their translations into Slovenian

Data from a multicenter open label randomized trial support the use of docetaxel for the adjuvant treatment of patients with operable node-negative breast cancer eligible to receive chemotherapy.
Podatki multicentričnega, odprtega randomiziranega preskušanja podpirajo uporabo zdravila Docetaksel Teva za adjuvantno zdravljenje bolnic z operabilnim rakom dojke z negativnimi bezgavkami, primernih za prejemanje kemoterapije.

results of the multicenter AART study…”.
rezultati multicentrične študije AART.

A Multicenter, Multinational Study to Assess the Safety
Multicentricna, multinacionalna študija za ocenitev varnosti

active- controlled, multicenter study(GS-US-205-0110).
aktivno kontrolirani multricentrični študiji(GS-US-205-0110).

The efficacy of ChondroCelect was studied in a phase III, multicenter, randomized, controlled trial(TIG/ACT/01/2000)
Učinkovitost zdravila ChondroCelect je bila preučevana v multicentrični, randomizirani, kontrolirani študiji III. faze(TIG/ACT/01/2000)

The safety and efficacy of Humira was assessed in an open-label, multicenter study in 32 children(2-<
Varnost in učinkovitost zdravila Humira so ocenili v odprti, multicentrični študiji pri 32 otrocih(starih od 2 do<

The efficacy and safety of InductOs were demonstrated in a randomised, controlled, multicenter, non- inferiority study of 279 patients aged 19- 78 years undergoing an open anterior lumbar interbody fusion procedure.
Učinkovitost in varnost zdravila InductOs je dokazala randomizirana, kontrolirana multicentrična raziskava neinferiornosti pri 279 bolnikih, starih od 19 do 78 let, ki jim je bila narejena prednja ledvena interkorpusna fuzija.

The safety and efficacy of Humira were assessed in a multicenter, randomised, double-blind study in 46 paediatric patients(6 to 17 years old)
Varnost in učinkovitost zdravila Humira so ocenili v multicentrični, randomizirani, dvojno slepi študiji pri 46 pediatričnih bolnikih(starih od 6 do 17 let) z zmernim artritisom,

A phase 3 randomized, multicenter, international, study evaluating the efficacy
Narejena je bila randomizirana, multicentrična mednarodna študija 3. faze za oceno učinkovitosti

A multicenter, open-label, randomized trial, was conducted to evaluate the safety
Opravljeno je bilo multicentrično, odprto, randomizirano preskušanje za oceno varnosti

The safety and efficacy of IMBRUVICA in patients previously treated for CLL were further evaluated in a randomised, multicenter, double-blinded phase 3 study of IMBRUVICA in combination with BR versus placebo+ BR(Study CLL3001).
Varnost in učinkovitost zdravila IMBRUVICA pri bolnikih, predhodno zdravljenih za KLL so ocenjevali tudi v randomizirani, multicentrični, dvojno slepi študiji faze 3, kjer so primerjali zdravilo IMBRUVICA v kombinaciji z BR in kombinacijo placebo+ BR(študija CLL3001).

was a multicenter, randomized, double-blind,
je bila multicentrična, randomizirana, dvojno slepa,

A multicenter, multinational, randomized, open-label study was
Pri 861 bolnikih so opravili multicentrično, multinacionalno, randomizirano,

for pediatric safety and secondarily for efficacy in randomized comparative, multicenter studies in patients 3 months to 17 years of age.
sekundarno z namenom presoje učinkovitosti v randomiziranih, primerjalnih, multicentričnih raziskavah pri pediatričnih bolnikih, starih od 3 mesece do 17 let.

Voriconazole was compared to itraconazole as primary prophylaxis in an open-label, comparative, multicenter study of adult and adolescent allogeneic HSCT
V odprti primerjalni multicentrični študiji so primerjali vorikonazol

The second paediatric, trial was a multicenter, double-blind, double-dummy,
Drugo pediatrično preskušanje je bila multicentrična, dvojno slepa,

A multicenter, open-label, single-arm study of pertuzumab in combination with trastuzumab
Multicentrično, odprto, preskušanje pertuzumaba z enim krakom v kombinaciji s trastuzumabom

In a multicenter, double-blind, placebo-controlled, 14 week study, 13 patients with heterozygous familial hypercholesterolaemia(heFH)
V multicentrični dvojno slepi s placebom kontrolirani 14-tedenski študiji so 13 bolnikov s heterozigotno familiarno hiperholesterolemijo(heFH)

A multicenter, open-label, randomized study was conducted to evaluate the safety
Opravljena je bila multicentrična, odprta, randomizirana študija za oceno varnosti

A multicenter, randomised, open-label, trial was conducted
Opravili so multicentrično, randomizirano, odprto preskušanje,